Maloberti A., Giannattasio C., Bombelli M. et al. Hyperuricemia and risk of cardiovascular outcomes: the experience of the URRAH (Uric Acid Right for Heart Health) project // High Blood Pressure and Cardiovascular Prevention. 2020. Vol. 27, № 2. P. 121–128. https://doi.org/10.1007/s40292-020-00368-z..
DOI: 10.1007/s40292-020-00368-z
Шальнова С. А., Деев А. Д., Артамонова Г. В. и др. Гиперурикемия и ее корреляты в российской популяции (результаты эпидемиологического исследования эссе-рф) // Рациональная фармакотерапия в кардиологии. 2014. Т. 10, № 2. С. 153–159. https://doi.org/10.20996/1819-6446-2014-10-2-153-159..
DOI: 10.20996/1819-6446-2014-10-2-153-159
Головач И. Ю., Егудина Е. Д., Тер-Вартаньян С. Х. Бессимптомная гиперурикемия: тайные взаимосвязи, невидимые эффекты и потенциальные осложнения // Научнопрактическая ревматология. 2020. Т. 58, № 6. С. 725–733. https://doi.org/10.47360/1995-4484-2020-725-733..
DOI: 10.47360/1995-4484-2020-725-733
Либов И. А., Моисеева Ю. Н., Комарова А. Г. Гиперурикемия как фактор риска сердечно-сосудистых осложнений у пациентов с артериальной гипертонией // Российский кардиологический журнал. 2022. Т. 27, № 9. С. 5194. https://doi.org/10.15829/1560-4071-2022-5194..
DOI: 10.15829/1560-4071-2022-5194
Freilich M., Arredondo A., Zonnoor S. L., McFarlane I. M. Elevated serum uric acid and cardiovascular disease: a review and potential therapeutic interventions // Cureus. 2022. Vol. 14, № 3. P. e23582. https://doi.org/10.7759/cureus..
DOI: 10.7759/cureus
Grassi G., Vanoli J., Facchetti R., Mancia G. Uric acid, hypertensive phenotypes, and organ damage: data from the Pamela study // Curr Hypertens Rep. 2022. Vol. 24, № 2. P. 29–35. https://doi.org/10.1007/s11906-022-01174-9..
DOI: 10.1007/s11906-022-01174-9
Li M., Hu X., Fan Y. et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality: a systematic review and dose-response meta-analysis //sci Rep. 2016. Vol. 6. P. 19520. https://doi.org/10.1038/srep19520..
DOI: 10.1038/srep19520
Gao Z., Shi H., Xu W. et al. Hyperuricemia increases the risk of atrial fibrillation: a systematic review and meta-analysis //int J Endocrinol. 2022. Vol. 2022. P. 8172639. https://doi.org/10.1155/2022/8172639..
DOI: 10.1155/2022/8172639
Raya-Cano E., Vaquero-Abellán M., Molina-Luque R. et al. Association between metabolic syndrome and uric acid: a systematic review and meta-analysis //sci Rep. 2022. Vol. 12, № 1. P. 18412. https://doi.org/10.1038/s41598-022-22025-2..
DOI: 10.1038/s41598-022-22025-2
Gonçalves D. L. N., Moreira T. R., da Silva L. S. A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease //sci Rep. 2022. Vol. 12, № 1. P. 6251. https://doi.org/10.1038/s41598-022-10118-x..
DOI: 10.1038/s41598-022-10118-x
Borghi C., Agabiti-Rosei E., Johnson R. J. et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease // Eur J Intern Med. 2020. Vol. 80. P. 1–11. https://doi.org/10.1016/j.ejim.2020.07.006..
DOI: 10.1016/j.ejim.2020.07.006
Kikuchi A., Kawamoto R., Ninomiya D., Kumagi T. Hyperuricemia is associated with all-cause mortality among males and females: findings from a study on Japanese community-dwelling individuals // Metabolism Open. 2022. Vol. 14. P. 100186. https://doi.org/10.1016/j.metop.2022.100186..
DOI: 10.1016/j.metop.2022.100186
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2023. URL: https://goldcopd.org/ (accessed: 20.12.24).https://goldcopd.org/
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2023. URL: https://goldcopd.org/ (accessed: 20.12.24).https://goldcopd.org/
Masannagari P., Chaitra H. B., Choudhary A., Rajashekaraiah V. Influence of uric acid on erythrocytes subjected to H₂O₂-induced oxidative stress // Appl In Vitro Toxicol. 2023. Vol. 9, № 2. P. 37–43. https://doi.org/10.1089/aivt.2023.0001..
DOI: 10.1089/aivt.2023.0001
Ma P., Zhao M., Li Y. et al. The protective effects of uric acid against myocardial ischemia via the Nrf2 pathway // Eur J Pharmacol. 2023. Vol. 959. P. 176062. https://doi.org/10.1016/j.ejphar.2023.176062..
DOI: 10.1016/j.ejphar.2023.176062
Галунска Б., Паскалев Д., Янкова Т., Чанкова П. Двуликий Янус биохимии: мочевая кислота – оксидант или антиоксидант? // Нефрология. 2004. Т. 8, № 4. С. 25–31. URL: https://cyberleninka.ru/article/n/dvulikiy-yanus-biohimii-mochevaya-kislota-oksidant-ili-antioksidant (дата обращения: 20.12.24).https://cyberleninka.ru/article/n/dvulikiy-yanus-biohimii-mochevaya-kislota-oksidant-ili-antioksidant
Галунска Б., Паскалев Д., Янкова Т., Чанкова П. Двуликий Янус биохимии: мочевая кислота – оксидант или антиоксидант? // Нефрология. 2004. Т. 8, № 4. С. 25–31. URL: https://cyberleninka.ru/article/n/dvulikiy-yanus-biohimii-mochevaya-kislota-oksidant-ili-antioksidant (дата обращения: 20.12.24).https://cyberleninka.ru/article/n/dvulikiy-yanus-biohimii-mochevaya-kislota-oksidant-ili-antioksidant
Kurajoh M., Fukumoto S., Yoshida S. et al. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry //sci Rep. 2021. Vol. 11, № 1. P. 7378. https://doi.org/10.1038/s41598-021-86962-0..
DOI: 10.1038/s41598-021-86962-0
Zhang M., Cui R., Zhou Y. et al. Uric acid accumulation in the kidney triggers mast cell degranulation and aggravates renal oxidative stress // Toxicology. 2022. Vol. 483. P. 153387. https://doi.org/10.1016/j.tox.2022.153387..
DOI: 10.1016/j.tox.2022.153387
Kahnert K., Alter P., Welte T. et al. Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach // Respir Res. 2018. Vol. 19. P. 110. https://doi.org/10.1186/s12931-018-0815-y..
DOI: 10.1186/s12931-018-0815-y
Embarak S., Sileem A. E., Abdrabboh M., Mokhtar A. Serum uric acid as a biomarker for prediction of outcomes of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease // Egypt J Bronchol. 2014. Vol. 8. P. 115–120. https://doi.org/10.4103/1687-8426.145703..
DOI: 10.4103/1687-8426.145703
Embarak S., Sileem A. E., Abdrabboh M., Mokhtar A. Serum uric acid as a biomarker for prediction of outcomes of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease // Egypt J Bronchol. 2014. Vol. 8. P. 115–120. https://doi.org/10.4103/1687-8426.145703..
DOI: 10.4103/16878426.145703
Bartziokas K., Papaioannou A. I., Loukides S. et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD // Eur Respir J. 2014. Vol. 43, № 1. P. 43–53. https://doi.org/10.1183/09031936.00209212..
DOI: 10.1183/09031936.00209212
Kobylecki C. J., Vedel-Krogh S., Afzal S. et al. Plasma urate, lung function and chronic obstructive pulmonary disease: a Mendelian randomisation study in 114 979 individuals from the general population // Thorax. 2018. Vol. 73. P. 748–757. https: //dx.doi.org/10.1136/thoraxjnl-2017-210273..
DOI: 10.1136/thoraxjnl-2017-210273
Yang H., Wang Z., Xiao S. et al. Association between serum uric acid and lung function in people with and without chronic obstructive pulmonary disease //int J Chron Obstruct Pulmon Dis. 2022. Vol. 2022. P. 1069–1080. https://dx.doi.org/10.2147/COPD.S356797..
DOI: 10.2147/COPD.S356797
Sahana K., Sivaranjani H. Uric acid: a mirror to the lungs in COPD // J Assoc Physicians India. 2022. Vol. 70, № 4. P. 11–2. PMID: 35443464.
Sharaf El Din U. A., Salem M. M., Abdulazim D. O. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review // J Adv Res. 2017. Vol. 8, № 5. P. 537–548. https://dx.doi.org/10.1016/j.jare.2016.11.004..
DOI: 10.1016/j.jare.2016.11.004
Jayashankar C. A., Andrews H. P., Vijayasarathi et al. Serum uric acid and low-density lipoprotein cholesterol levels are independent predictors of coronary artery disease in Asian Indian patients with type 2 diabetes mellitus // J Nat Sci Biol Med. 2016. Vol. 7, № 2. P. 161–165. https://doi.org/10.4103/0976-9668.184703..
DOI: 10.4103/0976-9668.184703
Tscharre M., Herman R., Rohla M. et al. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention // Atherosclerosis. 2018. Vol. 270. P. 173–179. https://dx.doi.org/10.1016/j.atherosclerosis.2018.02.003..
DOI: 10.1016/j.atherosclerosis.2018.02.003
Magnoni M., Berteotti M., Ceriotti F. et al. Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome //int J Cardiol. 2017. Vol. 240. P. 25–29. https://doi.org/10.1016/j.ijcard.2017.04.027..
DOI: 10.1016/j.ijcard.2017.04.027
Eckner D., Popp S., Wicklein S., Pauschinger M. Acute coronary syndrome in older people // Gerontol Geriatr. 2018. Vol. 51, № 4. P. 461–475. (In German) https://dx.doi.org/10.1007/s00391-018-1411-y..
DOI: 10.1007/s00391-018-1411-y
Pagidipati N. J., Hess C. N., Clare R. M. et al. An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome // Am Heart J. 2017. Vol. 187. P. 53–61. https://doi.org/10.1016/j.ahj.2017.02.023..
DOI: 10.1016/j.ahj.2017.02.023
Guo G., Huang Z., Wang S., Chen X. Sex differences in uric acid and NT-proBNP assessments during coronary severity // Medicine (Baltimore). 2020. Vol. 99, № 15. P. e19653. https://dx.doi.org/10.1097/MD.0000000000019653..
DOI: 10.1097/MD.0000000000019653
Spahic E., Hasic S., Kiseljakovic E. et al. Positive correlation between uric acid and C-reactive protein serum level in healthy individuals and patients with acute coronary syndromes // Med Glas (Zenica). 2015. Vol. 12, № 2. P. 128–132. https://doi.org/10.17392/821..
DOI: 10.17392/821
Saito Y., Kitahara H., Nakayama T. et al. Relation of elevated serum uric acid level to endothelial dysfunction in patients with acute coronary syndrome // J Atheroscler Thromb. 2019. Vol. 26, № 4. P. 362–7. https://doi.org/10.5551/jat.45179..
DOI: 10.5551/jat.45179
Kobayashi N., Hata N., Tsurumi M. et al. Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to serum uric acid levels in patients with acute coronary syndrome // Am J Cardiol. 2018. Vol. 122, № 1. P. 17–25. https://dx.doi.org/10.1016/j.amjcard.2018.03.022..
DOI: 10.1016/j.amjcard.2018.03.022
Karim B., Nasution S. A., Wijaya I. P., Harimurti K. Hyperuricemia as a risk factor of major adverse cardiac events in patients with acute coronary syndrome: a retrospective cohort study // Acta Med Indones. 2015. Vol. 47, № 4. P. 320–5. PMID: 26932701.
Lopez-Pineda A., Cordero A., Carratala-Munuera C. et al. Hyperuricemia as a prognostic factor after acute coronary syndrome // Atherosclerosis. 2018. Vol. 269. P. 229–235. PMID: 29407598. https://dx.doi.org/10.1016/j.atherosclerosis.2018.01.017..
DOI: 10.1016/j.atherosclerosis.2018.01.017
Cuifang He, Peihuan Lin, Wenbin Liu, Kuifa Fang. The prognostic value of hyperuricemia in patients with acute coronary syndrome: a meta-analysis // Eur J Clin Invest. 2019. Vol. 49, № 4. P. e13074. PMID: 30701529. https://doi.org/10.1111/eci.13074..
DOI: 10.1111/eci.13074